뇌경색과 뇌출혈로 발현한 시클로포스파미드와 연관된 가역적뇌혈관수축증후군
Cyclophosphamide-Associated Reversible Cerebral Vasoconstriction Syndrome Presenting as Concurrent Cerebral Infarction and Subarachnoid Hemorrhage
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Reversible cerebral vasoconstriction syndrome (RCVS) has several trigger factors, including physical exertion, pregnancy, and the intake of vasoconstrictive agents. These triggers activate the sympathetic nervous system and induce vasoconstriction, thereby leading to an ischemic or hemorrhagic stroke. In this study, we describe case of RCVS in a 73-year-old woman who complained of sudden bilateral leg weakness after taking cyclophosphamide for anti-neutrophil cytoplasmic antibody associated vasculitis. She was diagnosed with concurrent cerebral hemorrhage and cerebral infarction with multiple intracranial vasoconstrictions on imaging analyses.
Abstract
Reversible cerebral vasoconstriction syndrome (RCVS) has several trigger factors, including physical exertion, pregnancy, and the intake of vasoconstrictive agents. These triggers activate the sympathetic nervous system and induce vasoconstriction, thereby leading to an ischemic or hemorrhagic stroke. In this study, we describe case of RCVS in a 73-year-old woman who complained of sudden bilateral leg weakness after taking cyclophosphamide for anti-neutrophil cytoplasmic antibody associated vasculitis. She was diagnosed with concurrent cerebral hemorrhage and cerebral infarction with multiple intracranial vasoconstrictions on imaging analyses.
참고문헌 (8)
- Choi HA, "Cerebral endothelial dysfunction in reversible cerebral vasoconstriction syndrome: a case-control study", J Headache Pain, 18, pp.1~6 (2017)
- Herrmann J, "Vascular toxic effects of cancer therapies", Nat Rev Cardiol, 17, pp.503~522 (2020)
- Singhal AB, "Reversible cerebral vasoconstriction syndromes: what the cardiologist should know", Curr Treat Options Cardiovasc Med, 16, pp.290~ (2014)
- Topcuoglu MA, "Cerebral vasomotor reactivity in reversible cerebral vasoconstriction syndrome", Cephalalgia, 37, pp.541~547 (2017)
- Lee MJ, "Blood-brain barrier breakdown in reversible cerebral vasoconstriction syndrome:implications for pathophysiology and diagnosis", Ann Neurol, 81, pp.454~466 (2017)
- Ancker OV, "The adverse effect of hypertension in the treatment of thyroid cancer with multi-kinase inhibitors", Int J Mol Sci, 18, pp.625~ (2017)
- Headache Classification Committee of the International Headache Society (IHS), "The international classification of headache disorders, 3rd edition (beta version)", Cephalalgia, 33, pp.629~808 (2013)
- Wolff V, "Reversible cerebral vasoconstriction syndrome without typical thunderclap headache", Headache, 56, pp.674~687 (2016)